Functional genetic screens are a powerful tool for establishing links between genotypes and phenotypes. They are particularly relevant for identifying potential genetic factors underpinning disease onset or progression. Over the past decade, technological and methodological breakthroughs have advanced screening processes. In particular, the emergence of CRISPR allows researchers to modulate gene expression in a controlled, robust, and highly specific manner.
Download this ebook from Synthego to learn how researchers use CRISPR-mediated loss-of-function screens to identify and validate gene targets for drug discovery.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.